---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-019053"
form_type: "8-K"
ticker: "CPIX"
cik: "0001087294"
company_name: "CUMBERLAND PHARMACEUTICALS INC"
filed_at: "2024-04-29T23:59:59+00:00"
generated_at: "2026-06-03T05:22:47.974162+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cumberland Pharmaceuticals shareholders re-elect directors, ratify auditor at annual meeting

## Summary
- Martin S. Brown, Jr. re-elected as Class II director with 96.0% of votes in favor (8,544,756 for, 352,239 withheld).
- James R. Jones re-elected as Class II director with 94.5% of votes in favor (8,411,468 for, 485,527 withheld).
- Ratification of Carr, Riggs & Ingram LLC as auditor for FY2024 passed with 99.9% of votes in favor (11,189,440 for, 15,502 against).

## SEC filing metadata
- accession: 0001628280-24-019053
- form_type: 8-K
- ticker: CPIX
- cik: 0001087294
- company_name: CUMBERLAND PHARMACEUTICALS INC
- filed_at: 2024-04-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1087294/000162828024019053/0001628280-24-019053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1087294/000162828024019053/cpix-20240429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-019053
- JSON: https://secwatch.observer/filing/0001628280-24-019053.json
- Plain text: https://secwatch.observer/filing/0001628280-24-019053.txt

## Key facts
- Shareholder Votes
  CUMBERLAND PHARMACEUTICALS INC shareholders approved Election of two Class II Directors at the 2024-04-23 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-04-23
  source text: For Against Withheld Abstentions % of Votes in Favor Martin S. Brown, Jr. 8,544,756 — 352,239 — 96.0% James R. Jones 8,411,468 — 485,527 — 94.5%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1087294/000162828024019053/0001628280-24-019053-index.htm
- Shareholder Votes
  CUMBERLAND PHARMACEUTICALS INC shareholders approved Ratification of appointment of Carr, Riggs & Ingram, LLC as independent registered public accounting firm for year ending December 31, 2024 at the 2024-04-23 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-04-23
  source text: Appointment of Carr, Riggs & Ingram LLC as our independent registered public accounting firm for the year ending December 31, 2024 11,189,440 15,502 — 28,560 99.9%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1087294/000162828024019053/0001628280-24-019053-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.